GB Sciences SG&A Expense (Semi Annual) Trends

GB Sciences, Inc. (GBLX)

0.0003 0.00 (0.00%) USD | OTCM | Apr 06, 11:12

View SG&A Expense (Semi Annual) for GBLX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Plus Therapeutics, Inc.	--
BioStem Technologies, Inc.	--
Iovance Biotherapeutics, Inc.	--
Protokinetix, Inc.	--
Travere Therapeutics, Inc.	--